Skip to main content

Advertisement

SpringerLink
Log in

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The use of lymphatic microvessel density (LVD) and pro-lymphangiogenic mediators as prognostic factors for survival in breast cancer remains controversial. We searched the electronic databases PubMed and EMBASE without language restrictions for relevant literature to aggregate the survival results. To be eligible, every study had to include the assessment of the LVD or the expression of vascular endothelial growth factor (VEGF)-C or -D in patients with breast cancer and provide a survival comparison, including disease-free survival (DFS) or overall survival (OS), according to the LVD, VEGF-C or VEGF-D status. Across all studies, 56.64 % of patients were considered to have a VEGF-C-positive tumor, and 65.54 % of patients had VEGF-D-positive tumors. High LVD had an unfavorable impact on DFS, with a pooled hazard ratio (HR) of 2.222 (95 % CI 1.579–3.126) and an OS with a HR of 2.493 (95 % CI 1.183–5.25). According to the different lymphatic makers, the subgroup HR in the D2-40 studies was 2.431 (95 % CI 1.622–3.644) for DFS and 4.085 (95 % CI 1.896–8.799) for OS. VEGF-C overexpression, as assessed by immunochemistry, was a prognostic factor for decreased DFS (HR 2.164; 95 % CI 1.256–3.729) and for decreased OS (HR 2.613; 95 % CI 1.637–4.170). VEGF-D overexpression was a significant although weak prognostic factor for DFS only when assessed by immunochemistry, with a HR of 2.108 (95 % CI 1.014–4.384). Our meta-analysis demonstrated that LVD, VEGF-C and VEGF-D could predict poor prognosis in patients with breast cancer. However, standardization of the assessment of LVD and for the expression of lymphangiogenesis factors is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57:43–66

    Article  PubMed  Google Scholar 

  2. Saurel CA, Patel TA, Perez EA (2010) Changes to adjuvant systemic therapy in breast cancer: a decade in review. Clin Breast Cancer 10:196–208

    Article  PubMed  Google Scholar 

  3. Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16:1723–1739

    Article  PubMed  CAS  Google Scholar 

  4. Hayes DF (2008) Prognostic and predictive factors revisited. Breast 14:493–499

    Article  Google Scholar 

  5. Callagy GM, Webber MJ, Pharoah PD, Caldas C (2008) Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 8:153

    Article  PubMed  Google Scholar 

  6. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P (2008) Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 17:323–334

    Article  PubMed  CAS  Google Scholar 

  7. de Azambuja E, Cardoso F, de Castro G, Colozza M Jr, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96:1504–1513

    Article  PubMed  Google Scholar 

  8. Wang L, Shao ZM (2006) Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Invest 24:581–587

    Article  PubMed  CAS  Google Scholar 

  9. Uzzan B, Nicolas P, Cucherat M, Perret GY (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64:2941–2955

    Article  PubMed  CAS  Google Scholar 

  10. Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946–953

    Article  PubMed  CAS  Google Scholar 

  11. Karkkainen MJ, Alitalo K (2002) Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 13:9–18

    Article  PubMed  CAS  Google Scholar 

  12. Da MX, Wu Z, Tian HW (2008) Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 39:365–372

    Article  PubMed  CAS  Google Scholar 

  13. Cao R, Björndahl MA, Religa P, Clasper S, Garvin S, Galter D, Meister B, Ikomi F, Tritsaris K, Dissing S, Ohhashi T, Jackson DG, Cao Y (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345

    Article  PubMed  CAS  Google Scholar 

  14. Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A (2004) Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A 101:11658–11663

    Article  PubMed  CAS  Google Scholar 

  15. Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M (2006) Clinical patterns of metastasis. Cancer Metastasis Rev 25:221–232

    Article  PubMed  Google Scholar 

  16. Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, Jahnke K, Hauschild A, Hirakawa S, Mihm MC, Detmar M (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18:1232–1242

    Article  PubMed  Google Scholar 

  17. Brychtova S, Bezdekova M, Brychta T, Tichy M (2008) The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 55:273–279

    PubMed  CAS  Google Scholar 

  18. Wang J, Zhao W, Guo Y, Zhang B, Xie Q, Xiang D, Gao J, Wang B, Chen Z (2009) The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis. Oncology 76:420–429

    Article  PubMed  CAS  Google Scholar 

  19. Duff SE, Jeziorska M, Kumar S, Haboubi N, Sherlock D, O’Dwyer ST, Jayson GC (2007) Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis 9:793–800

    Article  PubMed  CAS  Google Scholar 

  20. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192–198

    Article  PubMed  CAS  Google Scholar 

  21. Matsuura M, Onimaru M, Yonemitsu Y, Suzuki H, Nakano T, Ishibashi H, Shirasuna K, Sueishi K (2009) Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol 175:1709–1721

    Article  PubMed  CAS  Google Scholar 

  22. Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K (2008) Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res 14:7205–7214

    Article  PubMed  CAS  Google Scholar 

  23. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789–801

    Article  PubMed  CAS  Google Scholar 

  24. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394

    Article  PubMed  CAS  Google Scholar 

  25. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98:769–778

    Article  PubMed  CAS  Google Scholar 

  26. Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol 15:434–440

    Article  PubMed  Google Scholar 

  27. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18:705–719

    Article  PubMed  CAS  Google Scholar 

  28. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834

    Article  PubMed  CAS  Google Scholar 

  29. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335–371

    Article  PubMed  CAS  Google Scholar 

  30. Gisterek I, Matkowski R, Lacko A, Sedlaczek P, Szewczyk K, Biecek P, Halon A, Staszek U, Szelachowska J, Pudelko M, Bebenek M, Harlozinska-Szmyrka A, Kornafel J (2010) Serum vascular endothelial growth factors A, C and D in human breast tumors. Pathol Oncol Res 16:337–344

    Article  PubMed  CAS  Google Scholar 

  31. Li EX, Shi F, Wu YY, Wu Y, Guo JJ, Dong DF (2008) The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer. Zhonghua Yi Xue Za Zhi 88:88–91

    PubMed  CAS  Google Scholar 

  32. Al-Mowallad A, Kirwan C, Byrne G, McDowell G, Li C, Stewart A, Al-Qouzi A, Kumar S (2007) Vascular endothelial growth factor-C in patients with breast cancer. In Vivo 21:549–551

    PubMed  CAS  Google Scholar 

  33. Zhang GH, Yang WT, Zhou XY, Zeng Y, Lu HF, Shi DR (2007) Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer. Zhonghua Yi Xue Za Zhi 87:155–160

    PubMed  CAS  Google Scholar 

  34. Fernandez-Aguilar S, Jondet M, Simonart T, Noel JC (2006) Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma. Breast 15:782–785

    Article  PubMed  Google Scholar 

  35. Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P (2006) Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 99:135–141

    Article  PubMed  CAS  Google Scholar 

  36. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2003) The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 88:1900–1908

    Article  PubMed  CAS  Google Scholar 

  37. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143–152

    Article  PubMed  CAS  Google Scholar 

  38. Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K (2005) Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91:125–132

    Article  PubMed  CAS  Google Scholar 

  39. Fu JM, Shi J, Zhou J (2009) Correlation analysis of vascular endothelial growth factor-C expression and clinicopathology in breast cancer. Nan Fang Yi Ke Da Xue Xue Bao 29:2266–2268

    PubMed  Google Scholar 

  40. Kim BC, Han SI, Lim SC (2009) Interpretation of Pin-1 and VEGF-C expression in breast infiltrating duct carcinoma. Oncol Rep 22:1381–1390

    PubMed  CAS  Google Scholar 

  41. Yasuoka H, Kodama R, Tsujimoto M, Yoshidome K, Akamatsu H, Nakahara M, Inagaki M, Sanke T, Nakamura Y (2009) Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer 9:220

    Article  PubMed  Google Scholar 

  42. Kadota K, Huang CL, Liu D, Ueno M, Kushida Y, Haba R, Yokomise H (2008) The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer 44:1057–1067

    Article  PubMed  CAS  Google Scholar 

  43. Gotte M, Kersting C, Radke I, Kiesel L, Wulfing P (2007) An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer Res 9:R8

    Article  PubMed  Google Scholar 

  44. Yavuz S, Paydas S, Disel U, Zorludemir S, Erdogan S (2005) VEGF-C expression in breast cancer: clinical importance. Adv Ther 22:368–380

    Article  PubMed  Google Scholar 

  45. Okada K, Osaki M, Araki K, Ishiguro K, Ito H, Ohgi S (2005) Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res 25:3003–3009

    PubMed  CAS  Google Scholar 

  46. Watanabe O, Kinoshita J, Shimizu T, Imamura H, Hirano A, Okabe T, Aiba M, Ogawa K (2005) Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer. J Exp Clin Cancer Res 24:75–82

    PubMed  CAS  Google Scholar 

  47. Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY (2004) Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10:7965–7971

    Article  PubMed  Google Scholar 

  48. Koyama Y, Kaneko K, Akazawa K, Kanbayashi C, Kanda T, Hatakeyama K (2003) Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. Clin Breast Cancer 4:354–360

    Article  PubMed  CAS  Google Scholar 

  49. Tsutsui S, Matsuyama A, Yamamoto M, Takeuchi H, Oshiro Y, Ishida T, Maehara Y (2010) The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer. Oncol Rep 23:621–630

    Article  PubMed  Google Scholar 

  50. Zhang GH, Zeng Y, Yang WT, Shi DR (2006) Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer. Zhonghua Bing Li Xue Za Zhi 35:473–477

    PubMed  CAS  Google Scholar 

  51. Gu Y, Qi X, Guo S (2008) Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis 25:717–725

    Article  PubMed  CAS  Google Scholar 

  52. El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ (2008) Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 129:578–586

    Article  PubMed  Google Scholar 

  53. Mohammed RA, Ellis IO, Elsheikh S, Paish EC, Martin SG (2009) Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat 113:261–273

    Article  PubMed  Google Scholar 

  54. Mylona E, Nomikos A, Alexandrou P, Giannopoulou I, Keramopoulos A, Nakopoulou L (2007) Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression. Histol Histopathol 22:825–835

    PubMed  CAS  Google Scholar 

  55. van der Schaft DW, Pauwels P, Hulsmans S, Zimmermann M, van de Poll-Franse LV, Griffioen AW (2007) Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site. Cancer Lett 254:128–136

    Article  PubMed  Google Scholar 

  56. Bono P, Wasenius VM, Heikkila P, Lundin J, Jackson DG, Joensuu H (2004) High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10:7144–7149

    Article  PubMed  CAS  Google Scholar 

  57. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240:306–312

    Article  PubMed  Google Scholar 

  58. Tezuka K, Onoda N, Takashima T, Ishikawa T, Wakasa T, Wakasa K, Hirakawa K (2008) Clinical significance of intra-tumoral sinusoidal structures showing lympho-endothelial immunoreactivity in breast cancer. Oncol Rep 20:25–32

    PubMed  Google Scholar 

  59. Gisterek I, Matkowski R, Koźlak J, Duś D, Lacko A, Szelachowska J, Kornafel J (2007) Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer—10 years follow-up analysis. Anticancer Res 27:2797–2802

    PubMed  CAS  Google Scholar 

  60. Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY (2008) Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 8:4

    Article  PubMed  Google Scholar 

  61. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092–1100

    Article  PubMed  CAS  Google Scholar 

  62. Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L (2007) Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma. Eur J Surg Oncol 33:294–300

    Article  PubMed  CAS  Google Scholar 

  63. Bando H, Weich HA, Horiguchi S, Funata N, Ogawa T, Toi M (2006) The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Oncol Rep 15:653–659

    PubMed  CAS  Google Scholar 

  64. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K (2003) Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol 16:309–314

    Article  PubMed  Google Scholar 

  65. Yang W, Klos K, Yang Y, Smith TL, Shi D, Yu D (2002) ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer 94:2855–2861

    Article  PubMed  CAS  Google Scholar 

  66. Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66:159–164

    Article  PubMed  CAS  Google Scholar 

  67. Currie MJ, Hanrahan V, Gunningham SP, Morrin HR, Frampton C, Han C, Robinson BA, Fox SB (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 57:829–834

    Article  PubMed  CAS  Google Scholar 

  68. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K (2003) Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res 9:716–721

    PubMed  CAS  Google Scholar 

  69. Chen YN, Gu Y (2009) Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer. Ai Zheng 28:1337–1343

    Article  PubMed  CAS  Google Scholar 

  70. Guo GL, Yang GL, Li ZY, You J, Yang K, Huang DP, Hu XQ, Zhang XH (2008) The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer. Zhonghua Wai Ke Za Zhi 46:132–135

    PubMed  Google Scholar 

  71. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R, Birner P (2006) VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139:839–846

    Article  PubMed  Google Scholar 

  72. El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ (2009) Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast. Breast J 15:261–267

    Article  PubMed  Google Scholar 

  73. Olewniczak S, Chosia M, Kwas A, Kram A, Domagala W (2002) Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women. Pol J Pathol 53:183–188

    PubMed  Google Scholar 

  74. Partanen TA, Alitalo K, Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86:2406–2412

    Article  PubMed  CAS  Google Scholar 

  75. Valtola R, Salven P, Heikkilä P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381–1390

    Article  PubMed  CAS  Google Scholar 

  76. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257

    PubMed  Google Scholar 

  77. Kadota K, Huang CL, Liu D, Nakashima N, Yokomise H, Ueno M, Haba R (2010) The clinical significance of the tumor cell D2-40 immunoreactivity in non-small cell lung cancer. Lung Cancer 70:88–93

    Article  PubMed  Google Scholar 

  78. Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO, Christofori G, Augustin HG (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168:1045–1053

    Article  PubMed  CAS  Google Scholar 

  79. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL, Jackson DG (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320

    PubMed  CAS  Google Scholar 

  80. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2000) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883–1886

    Article  Google Scholar 

  81. Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG (2007) Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol 8:488–499

    Article  PubMed  Google Scholar 

  82. Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, Yu LK, Song Y (2009) Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. J Thorac Oncol 4:1094–1103

    Article  PubMed  Google Scholar 

  83. Delmotte P, Martin B, Paesmans M, Berghmans T, Mascaux C, Meert AP, Steels E, Verdebout JM, Lafitte JJ, Sculier JP (2002) VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis. Rev Mal Respir 19:577–584

    PubMed  CAS  Google Scholar 

  84. Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701

    Article  PubMed  Google Scholar 

  85. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94:1823–1832

    Article  PubMed  CAS  Google Scholar 

  86. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327

    PubMed  CAS  Google Scholar 

  87. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK (2004) Pathology: cancer cells compress intratumour vessels. Nature 427:695

    Article  PubMed  CAS  Google Scholar 

  88. Achen MG, McColl BK, Stacker SA (2005) Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7:121–127

    Article  PubMed  CAS  Google Scholar 

  89. Achen MG, Stacker SA (2006) Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 119:1755–1760

    Article  PubMed  CAS  Google Scholar 

  90. Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK (2005) Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65:9004–9011

    Article  PubMed  CAS  Google Scholar 

  91. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:819–825

    Article  PubMed  CAS  Google Scholar 

  92. Lin J, Lalani AS, Harding TC, Gonzalez M, Wu WW, Luan B, Tu GH, Koprivnikar K, VanRoey MJ, He Y, Alitalo K, Jooss K (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65:6901–6909

    Article  PubMed  CAS  Google Scholar 

  93. Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, Gao J, Rao Z, Chen Z (2009) Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem 107:134–143

    Article  PubMed  CAS  Google Scholar 

  94. Raica M, Cimpean AM, Ceausu R, Ribatti D (2011) Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer. Anticancer Res 31:1757–1764

    PubMed  CAS  Google Scholar 

  95. Wang J, Li K, Wang B, Bi J (2012) Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature. Mol Biol Rep 39:5331–5338

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Nature Science Foundation of China (30901788 and 81272619) and Shandong Provincial Nature Science Foundation (ZR2010HQ038 and ZR2010HM059).

Conflict of interest

We, the authors of this manuscript, have no financial or personal relationships to disclose that could inappropriately influence or bias this work.

Author information

Authors and Affiliations

  1. Department of Oncology, General Hospital, Jinan Command of People’s Liberation Army, Shifan Street 25, Tianqiao District, Jinan, 250031, China

    Jun Wang, Baocheng Wang, Jingwang Bi, Kainan Li, Xiuju Liang, Huili Chu & Huihui Jiang

  2. Department of Outpatient, Military Command of Shandong Province, Lixia District, Jinan, 250013, China

    Yan Guo

Authors
  1. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baocheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jingwang Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kainan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiuju Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Huili Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Huihui Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Wang.

Additional information

Jun Wang and Yan Guo have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Guo, Y., Wang, B. et al. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol Biol Rep 39, 11153–11165 (2012). https://doi.org/10.1007/s11033-012-2024-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2024-y

Keywords

Search

Navigation